Literature DB >> 19419786

Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia.

Hatice Türkeli, Tuncer Caycı, Emin Özgür Akgül, Enis Macit, Halil Yaman, Ibrahim Aydın, Hilmi Demirin, Hasan Alacam, Esin Ozkan, Erdinç Cakır, Ozgür Deren, Mehmet Kemal Erbil, Z Ilker Kunak, Kutlay Burat, Serif Akman.   

Abstract

Elevated plasma homocystein (Hcy) level has been recognized as an important risk factor for a number of cardiovascular diseases, peripheral arterial occlusive disease and venous thrombosis. A part of Hcy in the organism is turned to homocysteine thiolactone (HcyT) via a ring closure reaction, which gains rate in hyperhomocysteinemia, and in turn undergoes a hydrolytic reaction back to Hcy by paraoxonase enzyme (PON). Since this is a protective reflex action enzyme against hyperhomocysteinemia, we investigated how a mild hyperhomocysteinemic nutritional habit affected serum PON activity in a population-based study. The difference detected via enzymatic activity using the paraoxon substrate was statistically non-significant (p=0.19), suggesting a defective performance to reflect the expected significance. Determination of serum PON activity via substrate paraoxon yielded no significant difference in an acute mild hyperhomocysteinemic diet model in humans.
Copyright © 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419786     DOI: 10.1016/j.ijcard.2009.03.138

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Homocysteine levels in Indian women with Polycystic Ovary Syndrome.

Authors:  Mehmet Agilli; Fevzi Nuri Aydin; Tuncer Cayci; Yasemin Gulcan Kurt
Journal:  J Clin Diagn Res       Date:  2014-10-20

2.  The relationship between homocysteine and uric acid levels in gouty patients.

Authors:  Mehmet Agilli; Fevzi Nuri Aydin; Tuncer Cayci; Yasemin Gulcan Kurt
Journal:  J Korean Med Sci       Date:  2014-09       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.